Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Jul 3;23(9):1824–1833. doi: 10.1158/1055-9965.EPI-14-0062

Table 1.

General characteristics of included studies

Study Study Design Case
N
Control
N
Male
N
Female
N
Age
Range
Colon
Cancer
N
Rectal
Cancer
N
Total
N
CCFR Case-control 1163 977 1072 1068 20–81 445 286 2140
Colo 2&3 Case-control 87 125 117 95 38–86 59 27 212
DACHS Case-control 2376 2206 2752 1830 33–99 1422 949 4582
DALS Case-control 1116 1174 1261 1029 28–79 1112 0 2290
HPFS Nested case-
control
173 230 403 0 48–81 113 41 403
MEC Nested case-
control
328 346 361 313 45–76 241 81 674
NHS Nested case-
control
375 955 0 1330 44–69 285 86 1330
PHS Nested case-
control
375 389 764 0 40–85 286 84 764
PLCO Nested case-
control
486 415 518 383 55–75 320 161 901
PMH-CCFR Case-control 280 122 0 402 48–73 206 64 402
OFCCR Case-control 650 522 562 610 29–77 433 197 1172
VITAL Nested case-
control
285 288 300 273 50–76 215 66 573
WHI Nested case-
control
1466 1531 0 2997 50–79 1149 261 2997

Total 9160 9280 8110 10330 20–99 6286 2303 18440